Investor Presentaiton

LANDAUERⓇ Q3 FY2017 and Q3 FY2016 Comparable Results ($ Millions) Q3 FY2017 As Reported Q3 FY2017 Medical Products Q3 FY2017 Comparable, Excluding Divestiture* Adjustment Revenue Operating Income $39.9 $ - $8.6 $ - ($ Millions) Q3 FY2016 As Reported Revenue Operating Income * Non-GAAP financial measure $39.9 $8.6 Q3 FY2016 Medical Products Adjustment Q3 FY2016 Comparable, Excluding Divestiture* $37.9 $(0.8) $37.1 $7.7 $(0.1) $7.6 20 20

View entire presentation